Infections in Alcoholic Liver Disease

Clinics in Liver Disease

Volumn 16, Issue 4, 2012, Pages 783-803

  Kim, Angela C ^a   Epstein, Marcia E ^a   Gautam Goyal, Pranisha ^a   Doan, Thien Ly ^b  

^a Division of Infectious Disease ^*  (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Alcoholism; Bartonella quintana; Capnocytophaga canimorus; Klebsiella pneumoniae; Lung abscess; Spontaneous bacterial peritonitis; Tuberculosis; Vibrio vulnificus

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CASPOFUNGIN; CEFOTETAN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; HEPATITIS B VACCINE; IMIPENEM; ISONIAZID; METRONIDAZOLE; NORFLOXACIN; PEGINTERFERON; PENICILLIN G; PENICILLIN G SODIUM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG; VANCOMYCIN;

ACUTE HEMORRHAGIC PANCREATITIS; ALCOHOL LIVER DISEASE; ALCOHOLIC PANCREATITIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BACTERIAL PERITONITIS; CAPNOCYTOPHAGA INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DISULFIRAM LIKE REACTION; DRUG HYPERSENSITIVITY; DYSPNEA; EMPYEMA; ENDOCARDITIS; ENTERITIS; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS C; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; LISTERIOSIS; LIVER FAILURE; LIVER TOXICITY; LUNG ABSCESS; NAUSEA; NONHUMAN; PANCREAS PSEUDOCYST; REVIEW; RICKETTSIOSIS; THORAX RADIOGRAPHY; TOXIC HEPATITIS; TUBERCULOSIS; VERTIGO; VIBRIO VULNIFICUS INFECTION;

ANTI-BACTERIAL AGENTS; CENTRAL NERVOUS SYSTEM INFECTIONS; ENDOCARDITIS, BACTERIAL; GASTROINTESTINAL DISEASES; HUMANS; INFECTION; LIVER DISEASES, ALCOHOLIC; RESPIRATORY TRACT INFECTIONS; VIBRIO INFECTIONS;

EID: 84867972810     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2012.08.008     Document Type: Review

References (81)

1. Donowitz G.R. Acute pneumonia. Principles and practice of infectious diseases 2010, 891-916. Elsevier, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
2. Manfredi F., Daly W.J., Behnke R.H. Clinical observations of acute friedlander pneumonia. Ann Intern Med 1963, 58:642-653.
3. Pierce A.K., Sanford J.P. Aerobic gram-negative bacillary pneumonias. Am Rev Respir Dis 1974, 110:647-658.
4. Jong G.M., Hsiue T.R., Chen C.R., et al. Rapidly fatal outcome of bacteremic klebsiella pneumonia pneumonia in alcoholics. Chest 1995, 107(1):214-217.
5. Marina M., Strong C.A., Cliven R., et al. Bacteriology of anaerobic pleuropulmonary infections: preliminary report. Clin Infect Dis 1993, 16(Suppl 4):S256-S262.
6. Lorber B. Bacterial lung abscess. Principles and practice of infectious diseases 2010, 925-929. Elsevier, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
7. Jones H.W., Roberts J., Brantner J. Incidence of tuberculosis among homeless men. JAMA 1954, 155:222-223.
8. Friedman L.N., Sullivan G.M., Bovilaqua R.P., et al. Tuberculosis screening in alcoholics and drug addicts. Am Rev Respir Dis 1987, 136:1188-1192.
9. Diel R.S., Schneider K., Meywald-Walter K., et al. Epidemiology of tuberculosis in Hamburg, Germany: long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol 2002, 40:532-539.
10. Bobrik A., Danishevski K., Ershina K., et al. Prison health in Russia: the larger picture. J Public Health Policy 2005, 26:30-59.
11. Mendenhall C.L., Moritz T.E., Roselle G.A., et al. A study of nutritional support with oxandrolone in malnourished patient with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993, 17:564-576.
12. Segarra F., Sherman D.S. Relapses in pulmonary tuberculosis. Dis Chest 1967, 51:59-63.
13. Advisory Committee for Elimination of TB. Use of preventative therapy for tuberculosis infection in the United States. MMWR Recomm Rep 1990, 39:9-12.
14. Aronin S.I., Mukherjee S.K., West J.C. Review of pneumococcal endocarditis in adults in the penicillin era. Clin Infect Dis 1998, 26:165-171.
15. Powderly W.G., Stanley S.L., Medoff G. Pneumococcal endocarditis: report of a series and review of the literature. Rev Infect Dis 1986, 8:786-791.
16. Buchbinder A.N., Roberts W.C. Alcoholism-an important but unemphasized factor predisposing to infective endocarditis. Arch Intern Med 1973, 132:689-692.
17. Wolff M., Regnier B., Witchitz S., et al. Pneumococcal endocarditis. Eur Heart J 1984, 5(Supp C):77-80.
18. Martinez E., Miro J.M., Almirante B., et al. Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults. Clin Infect Dis 2001, 35:130-139.
19. Sandoe J.A. Capnocytophaga canimorus endocarditis. J Med Microbiol 2004, 53:245-248.
20. Slater L.N., Welch D.F. Bartonella, including cat-scratch. Principles and practice of infectious diseases 2010, 2995-3009. Elsevier, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
21. Maguina C., Garcia P.J., Gotuzzo E., et al. Bartonellosis (Carrión's disease) in the modern era. Clin Infect Dis 2001, 33(6):772-779.
22. Spach D.H., Kanter A.S., Dougherty M.J., et al. Bartonella (rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med 1995, 332:424-428.
23. Vinson J.W., Varela G., Molina-Pasquel C. Trench fever. III. Induction of clinical disease in volunteers inoculated with Rickettsia quintana propagated on blood agar. Am J Trop Med Hyg 1969, 18:713-722.
24. Relman D.A. Has trench fever returned?. N Engl J Med 1995, 332(7):463-464.
25. Raoult D., Fournier P.E., Vandenesch F., et al. Outcome and treatment of Bartonella endocarditis. Arch Intern Med 2003, 163:226-230.
26. Sakorafas G.H., Tsiotou A.G. Etiology and pathogenesis of acute pancreatitis: current concepts. J Clin Gastroenterol 2000, 30(4):343-356.
27. Jerrells T.R., Vidlak D., Strachota J.M. Alcoholic pancreatitis: mechanisms of viral infections as cofactors in the development of acute and chronic pancreatitis and fibrosis. J Leukoc Biol 2007, 81(2):430-439.
28. Frossard J.L., Steer M.L., Pastor C.M. Acute pancreatitis. Lancet 2008, 371(9607):143-152.
29. Lozano-Leon A., Iglesias-Canle J., Iglesias-Garcia J., et al. Citrobacter freundii infection after acute necrotizing pancreatitis in a patient with a pancreatic pseudocyst. J Med Case Rep 2011, 7(5):51.
30. Foust R.T. Infection of a pancreatic pseudocyst due to Candida albicans. South Med J 1996, 89(11):1104-1107.
31. Eshwara V.K., Mukhopadhyay C., Mohan S., et al. Two unique presentations of Achromobacter xylosoxidans infections in clinical settings. J Infect Dev Ctries 2011, 5(2):138-141.
32. Baron T.H., Morgan D.E. Acute necrotizing pancreatitis. N Engl J Med 1999, 340:1412-1417.
33. Such J., Runyon B.A. Spontaneous bacterial peritonitis. Clin Infect Dis 1998, 27:669-676.
34. Runyon B.A., Montano A.A., Akriviadis E.A., et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992, 117:215-220.
35. Brook I. The importance of lactic acid levels in body fluids in the detection of bacterial infections. Rev Infect Dis 1981, 1(3):470-478.
36. Zeni F., Tardy B., Vindimian M., et al. High levels of tumor necrosis factor-α and interleukin 6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis 1993, 17:218-223.
37. Alaniz C., Regal R.E. Spontaneous bacterial peritonitis: a review of treatment options. P T 2009, 34(4):204-210.
38. Gines P., Rimol A., Planas, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo controlled trial. Hepatology 1990, 12:716-724.
39. Lontos S., Gow P.J., Vaughan R.B., et al. Norfloxacin and trimethoprim-sulfamethoxazole have similar efficacy in the prevention of spontaneous bacterial peritonitis. Hepatology 2008, 23:252-255.
40. Mota A., Guedes F., Areias J., et al. Alcohol consumption among patients with hepatitis b infection in northern Portugal considering gender and hepatitis B virus genotype difference. Alcohol 2010, 44(2):149-156.
41. Schiff ER, Ozden N. Hepatitis C and alcohol. Alcohol Res Health 2003;27(3):232-9.
42. Okazaki T., Yoshihara H., Suzuki K., et al. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers. Scand J Gastroenterol 1994, 29:1039-1043.
43. Oliveira L.C., Silva T.E., Alves M.H. Arq Gastroenterol 2007, 44(3):195-200. [in Portuguese].
44. Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol 2000, 95(12):3374-3382.
45. Sheth N.K., Wisniewski T.R., Franson T.R. Survival of enteric pathogens in common beverages: an in vitro study. Am J Gastroenterol 1988, 83(6):658-660.
46. Brenner H., Rothenbacher D., Bode G., et al. Inverse graded relation between alcohol consumption and active infection with Helicobacter pylori. Am J Epidemiol 1999, 149:571-576.
47. Soleas G.J., Dam J., Carey M., et al. Toward the fingerprinting of wine: cultivar-related patterns of polyphenolic constituents in Ontario wines. J Agric Food Chem 1997, 45(10):3871-3880.
48. Vaquero M.J., Alberto M.R., Manca de Nadra M.C. Antibacterial effects of phenolic compounds from different wines. Food Contr 2007, 18:93-101.
49. Carpenter R.R., Petersdorf R.G. The clinical spectrum of bacterial meningitis. Am J Med 1962, 33:262-275.
50. Swartz M.N., Dodge P.R. Bacterial meningitis: a review of selected aspects. N Engl J Med 1965, 272:725-731.
51. Cherubin C.E., Marr J.S., Sierra M.F., et al. Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Am J Med 1981, 71:199-209.
52. Mylonakis E., Hohmann E.L., Calderwood S.B. Central nervous system infection with Listeria monocytogenes: 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine 1998, 77:313-336.
53. Brouwer M.C., van de Beek D., Heckenberg S.G., et al. Community-acquired Listeria monocytogenes meningitis in adults. Clin Infect Dis 2006, 43:1233-1238.
54. Weisfeld M., de Gans J., van der Ende A., et al. Community-acquired bacterial meningitis in alcoholic patients. PLoS One 2010, 5(2):e9102.
55. Denney C.F., Iragui V.J., Uher-Zak L.D., et al. Amebic meningoencephalitis caused by Balamuthia mandrillaris: case report and review. Clin Infect Dis 1997, 25:1354-1358.
56. MacGregor R.R., Louria D.B. Alcohol and infection. Curr Clin Top Infect Dis 1997, 17:291-315.
57. Neill M., Carpenter C.J. Other pathogenic vibrios. Principles and practice of infectious diseases 2010, 2787-2789. Elsevier, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
58. Jones M.K., Oliver J.D. Vibrio vulnificus: disease and pathogenesis. Infect Immun 2009, 77(5):1723-1733.
59. Powell J.L., Wright A.C., Wasserman S.S., et al. Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in vivo and in vitro models. Infect Immun 1997, 65:3713-3718.
60. Shin S.H., Shin D.H., Ryu P.Y., et al. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients' sera. FEMS Immunol Med Microbiol 2002, 33:133-138.
61. Mead P.S., Slutsker L., Dietz V., et al. Food-related illness and death in the United States. Emerg Infect Dis 1999, 5(5):607-625.
62. Klontz K.C., Lieb S., Schreiber M., et al. Syndromes of Vibrio vulnificus infections: clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med 1988, 109:318-323.
63. Chen S.C., Lee Y.T., Tsai S.J., et al. Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period. J Antimicrob Chemother 2012, 67(2):488-493.
64. Mouzin E., Mascola L., Tormey M., et al. Prevention of Vibrio vulnificus infections: assessment of regulatory educational strategies. JAMA 1997, 278:576-578.
65. Janda J.M., Graves M. Capnocytophaga. Principles and practice of infectious diseases 2010, 2991-2994. Elsevier, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
66. Butler T., Weaver R.E., Ramani T.K., et al. Unidentified gram-negative rod infection: a new disease of man. Ann Intern Med 1977, 86:1-5.
67. Kullberg B.J., Westendorp R.J., Van't Wout J.W., et al. Purpura fulminans and symmetrical peripheral gangrene caused by Capnocytophaga canimorus (formerly df-2) septicemia-A complication of dog bite. Medicine 1991, 70(5):287-292.
68. Pers C., Gahrn-Hansen B., Frederiksen W. Capnocytophaga canimorus septicemia in Denmark, 1982-1995: review of 39 Cases. Clin Infect Dis 1996, 23:71-75.
69. Walker D.H. The role of host factors in the severity of spotted fever and typhus rickettsioses. Ann N Y Acad Sci 1990, 590:10-19.
70. Sousa R., França A., Dória Nòbrega S., et al. Host- and microbe-related risk factors for and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients. J Infect Dis 2008, 198(4):576-585.
71. Walker D.H. Rickettsia rickettsii and other spotted fever group rickettsiae (Rocky Mountain spotted fever and other spotted fevers). Principles and practice of infectious diseases 2010, 2499-2507. Elsevier, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
72. Raoult D., Fournier P.E., Fenollar F., et al. Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa. N Engl J Med 2001, 344:1504-1510.
73. Walker D.H., Feng H.M., Ladner S., et al. Immunohistochemical diagnosis of typhus rickettsioses using an anti-lipopolysaccharide monoclonal antibody. Mod Pathol 1997, 10:1038-1042.
74. Verbeeck R.K. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur. J Clin Pharmacol 2008, 64:1147-1161.
75. Rodighiero V. Effects of liver disease on pharmacokinetics. An update. Clin Pharm 1999, 37(5):399-431.
76. Robles M., Toscano E., Cotta J., et al. Antibiotic-induced liver toxicity: mechanisms, clinical features and causality assessment. Curr Drug Saf 2010, 5:212-222.
77. MacLaren R. Hepatic and cholestatic diseases. Drug-induced diseases: prevention, detection, and management 2010, 771-798. American Society of Health-System Pharmacists, Inc, Bethesda (MD). 2nd edition. J.E. Tisdale, D.A. Miller (Eds.).
78. Kuffner E. Disulfiram and disulfiram-like reactions. Goldfrank's toxicologic emergencies 2011, 1143-1146. The McGraw-Hill Companies, New York. 9th edition. L.S. Nelson, N.A. Lewin, M.A. Howland (Eds.).
79. Kline S.S., Mauro V.F., Forney R.B., et al. Cefotetan-induced disulfiram-type reactions and hypoprothrombinemia. Antimicrobial Agents Chemother 1987, 31(9):1328-1331.
80. Williams C.S., Woodcock K.R. Do ethanol and metronidazole interact to produce a disulfiram-like reaction?. Ann Pharmacother 2000, 34:255-257.
81. Visapää J.P., Tillonen J.S., Kaihovaara P.S. Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother 2002, 36:971-974.